Western blotting and qRT-PCR assay were used to determine the effects of PAR4-siRNA-mediated PAR4 silencing on DNMT1, HDAC2, and p16 expression of ESCC cell lines. Here, F2RL3 is linked to esophageal squamous cell carcinoma.